Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Email this article to a Colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to My Articles & Searches Download to citation manager Citing Articles via HighWire Citing Articles via Google Scholar Articles by Shear, M. K. Articles by Papp, L. A. Search for Related Content PubMed Citation Articles by Shear, M. K. Articles by Papp, L. A. Panic Disorder Tests

Multicenter Collaborative Panic Disorder Severity Scale

OBJECTIVE: To address the lack of a simple and standardized instrument to assess overall panic disorder severity, the authors developed a scale for the measurement of panic disorder severity. METHOD: Ten independent evaluators used the seven-item Panic Disorder Severity Scale to assess 186 patients with principal DSM-III-R diagnoses of panic disorder (with no or mild agoraphobia) who were participating in the Multicenter Collaborative Treatment Study of Panic Disorder. In addition, 89 of these patients were reevaluated with the same scale after short-term treatment. A subset of 24 patients underwent two independent assessments to establish interrater reliability. Internal consistency, convergent and discriminant validity, and sensitivity to change were also determined. RESULTS: The Panic Disorder Severity Scale was associated with excellent interrater reliability, moderate internal consistency, and favorable levels of validity and sensitivity to change. Individual items showed good convergent and discriminant validity. Analysis suggested a two-factor model fit the data best. CONCLUSIONS: The Panic Disorder Severity Scale is a simple, efficient way for clinicians to rate severity in patients with established diagnoses of panic disorder. However, further research with more diverse groups of panic disorder patients and with a broader range of convergent and discriminant validity measures is needed. (Am J Psychiatry 1997; 154:1571–1575)

This article has been cited by other articles:

				D. E. Hinton, L. Hinton, M. Tran, M. Nguyen, L. Nguyen, C. Hsia, and M. H. Pollack Orthostatic Panic Attacks Among Vietnamese Refugees Transcultural Psychiatry, December 1, 2007; 44(4): 515 - 544. [Abstract] [PDF]

				B. Deacon Two-Day, Intensive Cognitive-Behavioral Therapy for Panic Disorder: A Case Study Behav Modif, September 1, 2007; 31(5): 595 - 615. [Abstract] [PDF]

				B. Milrod, A. C. Leon, F. Busch, M. Rudden, M. Schwalberg, J. Clarkin, A. Aronson, M. Singer, W. Turchin, E. T. Klass, et al. A Randomized Controlled Clinical Trial of Psychoanalytic Psychotherapy for Panic Disorder Am J Psychiatry, February 1, 2007; 164(2): 265 - 272. [Abstract] [Full Text] [PDF]

				T. A. FURUKAWA, N. WATANABE, and R. CHURCHILL Psychotherapy plus antidepressant for panic disorder with or without agoraphobia: Systematic review The British Journal of Psychiatry, April 1, 2006; 188(4): 305 - 312. [Abstract] [Full Text] [PDF]

				S. J. Mathew, J. M. Amiel, J. D. Coplan, H. A. Fitterling, H. A. Sackeim, and J. M. Gorman Open-Label Trial of Riluzole in Generalized Anxiety Disorder Am J Psychiatry, December 1, 2005; 162(12): 2379 - 2381. [Abstract] [Full Text] [PDF]

				B. L. Rollman, B. H. Belnap, S. Mazumdar, P. R. Houck, F. Zhu, W. Gardner, C. F. Reynolds III, H. C. Schulberg, and M. K. Shear A Randomized Trial to Improve the Quality of Treatment for Panic and Generalized Anxiety Disorders in Primary Care Arch Gen Psychiatry, December 1, 2005; 62(12): 1332 - 1341. [Abstract] [Full Text] [PDF]

				J. D. Huppert, L. T. Schultz, E. B. Foa, D. H. Barlow, J. R.T. Davidson, J. M. Gorman, M. K. Shear, H. B. Simpson, and S. W. Woods Differential Response to Placebo Among Patients With Social Phobia, Panic Disorder, and Obsessive-Compulsive Disorder Am J Psychiatry, August 1, 2004; 161(8): 1485 - 1487. [Abstract] [Full Text] [PDF]

				A. Neumeister, E. Bain, A. C. Nugent, R. E. Carson, O. Bonne, D. A. Luckenbaugh, W. Eckelman, P. Herscovitch, D. S. Charney, and W. C. Drevets Reduced Serotonin Type 1A Receptor Binding in Panic Disorder J. Neurosci., January 21, 2004; 24(3): 589 - 591. [Abstract] [Full Text] [PDF]

				A. E. Meuret, F. H. Wilhelm, T. Ritz, and W. T. Roth Breathing Training for Treating Panic Disorder: Useful Intervention or Impediment? Behav Modif, October 1, 2003; 27(5): 731 - 754. [Abstract] [PDF]

				M. H. Pollack, N. M. Simon, J. J. Worthington, A. L. Doyle, P. Peters, F. Toshkov, and M. W. Otto Combined Paroxetine and Clonazepam Treatment Strategies Compared to Paroxetine Monotherapy for Panic Disorder J Psychopharmacol, September 1, 2003; 17(3): 276 - 282. [Abstract] [PDF]

				V. Carli, M. Sarchiapone, G. Camardese, L. Romano, and S. DeRisio Mirtazapine in the Treatment of Panic Disorder Arch Gen Psychiatry, July 1, 2002; 59(7): 661 - 662. [Full Text] [PDF]

				M. K. Shear, P. Houck, C. Greeno, and S. Masters Emotion-Focused Psychotherapy for Patients With Panic Disorder Am J Psychiatry, December 1, 2001; 158(12): 1993 - 1998. [Abstract] [Full Text] [PDF]

				D. MICHELSON, C. ALLGULANDER, K. DANTENDORFER, A. KNEZEVIC, D. MAIERHOFER, V. MICEV, V. R. PAUNOVIC, I. TIMOTIJEVIC, N. SARKAR, L. SKOGLUND, et al. Efficacy of usual antidepressant dosing regimens of fluoxetine in panic disorder: Randomised, placebo-controlled trial The British Journal of Psychiatry, December 1, 2001; 179(6): 514 - 518. [Abstract] [Full Text] [PDF]

				A. E. Meuret, F. H. Wilhelm, and W. T. Roth Respiratory Biofeedback-Assisted Therapy in Panic Disorder Behav Modif, September 1, 2001; 25(4): 584 - 605. [Abstract] [PDF]

				P. P. Roy-Byrne, W. Katon, D. S. Cowley, and J. Russo A Randomized Effectiveness Trial of Collaborative Care for Patients With Panic Disorder in Primary Care Arch Gen Psychiatry, September 1, 2001; 58(9): 869 - 876. [Abstract] [Full Text] [PDF]

				A. W. Goddard, T. Brouette, A. Almai, P. Jetty, S. W. Woods, and D. Charney Early Coadministration of Clonazepam With Sertraline for Panic Disorder Arch Gen Psychiatry, July 1, 2001; 58(7): 681 - 686. [Abstract] [Full Text] [PDF]

				A. W. Goddard, G. F. Mason, A. Almai, D. L. Rothman, K. L. Behar, O. A. C. Petroff, D. S. Charney, and J. H. Krystal Reductions in Occipital Cortex GABA Levels in Panic Disorder Detected With 1H-Magnetic Resonance Spectroscopy Arch Gen Psychiatry, June 1, 2001; 58(6): 556 - 561. [Abstract] [Full Text] [PDF]

				D. H. Barlow, J. M. Gorman, M. K. Shear, and S. W. Woods Cognitive-Behavioral Therapy, Imipramine, or Their Combination for Panic Disorder: A Randomized Controlled Trial JAMA, May 17, 2000; 283(19): 2529 - 2536. [Abstract] [Full Text] [PDF]

				M. E. Wylie, M. D. Miller, M. K. Shear, J. T. Little, B. H. Mulsant, B. G. Pollock, and C. F. Reynolds Fluvoxamine Pharmacotherapy of Anxiety Disorders in Later Life: Preliminary Open-Trial Data J Geriatr Psychiatry Neurol, April 1, 2000; 13(1): 43 - 48. [Abstract] [PDF]

				D. Michelson, R. B. Lydiard, M. H. Pollack, R. N. Tamura, S. L. Hoog, R. Tepner, M. A. Demitrack, G. D. Tollefson, and the Fluoxetine Panic Disorder Study Group Outcome Assessment and Clinical Improvement in Panic Disorder: Evidence From a Randomized Controlled Trial of Fluoxetine and Placebo Am J Psychiatry, November 1, 1998; 155(11): 1570 - 1577. [Abstract] [Full Text]

				M. H. Pollack, M. W. Otto, J. J. Worthington, G. G. Manfro, and R. Wolkow Sertraline in the Treatment of Panic Disorder: A Flexible-Dose Multicenter Trial Arch Gen Psychiatry, November 1, 1998; 55(11): 1010 - 1016. [Abstract] [Full Text] [PDF]

Get information about faster international access.

Privacy Policy

Copyright © 1997 American Psychiatric Association. All rights reserved.

Home | Search | Current Issue | Past Issues | Subscribe | All APPI Journals | Help | Contact Us